Document › Details
Siemens Healthcare. (6/12/12). "Press Release: Siemens Showcases Broad Microbiology Portfolio and Affiliated Solutions at ASM 2012. Company Exhibit Demonstrates Strong Workflow Efficiency from Pre-analytical through Post-analytical Testing". San Francisc
|Region||San Francisco, CA|
|Country||United States (USA)|
|Organisation||Siemens Healthcare Diagnostics Inc.|
|Organisation 2||Bruker Daltonik GmbH|
|Group||Bruker Corporation (Group)|
|Product||MALDI Biotyper system|
|Product 2||diagnostics (medical/biological)|
|Index term 2||Siemens–Bruker Corp: mass spectrometer, 201105– collab strategic alliance co-marketing of MALDI Biotyper for proteomic fingerprinting|
Siemens Healthcare Diagnostics is showcasing its broad microbiology testing portfolio and affiliated solutions at the 112th American Society for Microbiology (ASM) General Meeting, San Francisco, June 17 - 19, 2012 (Booth #701). The exhibit - "Workflow Efficiency. Powered by Innovation." - highlights the latest technologies from Siemens and partners, Copan and Bruker, that help today's busy microbiology laboratories address their most challenging needs.
Exhibited solutions include Copan's WASP® (Walk-Away Specimen Processor), based on a strategic Siemens-Copan partnership formed in 2011. Specifically supporting pre-analytical workflow needs, the WASP enables laboratories to take advantage of fully automated bacteriology specimen processing. Individualized sample management, utilizing familiar streaking patterns, standardizes workflow processes and optimizes specimen set-up activities to free up staff resources. The enhanced functionality offered through the WASP complements analytical workflow features already available within the Siemens MicroScan® portfolio.
Bruker's MALDI Biotyper is also featured in Siemens' ASM booth, resulting from a strategic alliance established last year between the two companies. Providing fast, highly cost-effective molecular microorganism identification using MALDI-TOF mass spectrometry for proteomic fingerprinting, the MALDI Biotyper includes outstanding accuracy and sensitivity to meet a wide variety of laboratory demands. When combined with MicroScan's long history of superior, direct MIC testing accuracy, Bruker's next-generation technology offers Siemens' microbiology customers broader testing capabilities to support evolving clinical and process challenges. Plus, Siemens' new LabPro-MBT¹ software, also on display, seamlessly integrates MALDI Biotyper processing with MicroScan panel results to simplify mass spectrometry ID workflow.
The booth also showcases the LabPro Connect² networking software - the latest expansion to Siemens' MicroScan LabPro Information Management System, providing effective management of microbiology test results by consolidating databases for multiple testing systems and aggregating LabPro ID/AST data to bench and laboratory office computers.
Attendees can also view the Siemens Tissue Preparation Solution (TPS)³, the first fully automated method for extracting DNA and RNA from formalin-fixed, paraffin embedded (FFPE) tissue samples. The combination of an automated system and complete reagent kit that includes the ability to run three separate protocols provides pathologists with the ability to improve turnaround time, thereby impacting treatment decisions.
Unique education and training opportunities are available to attendees, including several in-booth theater presentations and an interactive Learning Center for Siemens' full spectrum of microbiology solutions. Additionally, visitors can receive a demonstration on Siemens' Personalized Education Plan (PEP) and PEP Administrator-an industry-first software program providing standardized, virtual competency-based education to advance staff development and improve productivity.
"As laboratories remain focused on delivering fast and accurate test results that aid in the diagnosis and treatment of critical illnesses, we continue to provide our customers with innovative products that help them achieve this goal," said Christoph Gauer, CEO, Molecular/Microbiology Business Segment, Siemens Healthcare Diagnostics. "Siemens' presence at ASM 2012 reconfirms our strong footprint in advanced microbiology testing innovations and highlights our strong progress in broadening our portfolio across the entire testing cycle."
These microbiology technologies demonstrate Siemens' innovative leadership, one of the goals of the recently launched Siemens Agenda 2013 program. For additional information about the Siemens solutions noted above, please visit: www.usa.siemens.com/microbiology.
¹ Under development. Not available for sale.
² LabPro Connect is currently available for laboratories located in the United States, Puerto Rico, and Canada. Additional country launches are also slated to occur this month.
³ Siemens partnered with Reno, Nevada-based Hamilton Company (www.hamiltoncompany.com) to develop the Tissue Preparation System. Hamilton is the worldwide leader in the design and manufacture of robotic products used for precision fluid measuring.
Launched in November 2011, Agenda 2013 is a global initiative to further strengthen the innovative power and competitiveness of the Siemens Healthcare Sector. Specific measures will be implemented in four fields of action: Innovation, Competitiveness, Regional Footprint, and People Development.
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2011 (to September 30), the Sector posted revenue of 12.5 billion euros and profit of around 1.3 billion euros. For further information please visit: www.siemens.com/healthcare.
Record changed: 2016-03-19
More documents for Siemens (Group)
-  Beckman Coulter, Inc.. (7/16/14). "Press Release: Beckman Coulter to Acquire Siemens Healthcare Diagnostics' Clinical Microbiology Business". Brea, CA....
-  Siemens Healthcare. (5/23/11). "Press Release: Siemens Bolsters Microbiology Portfolio through New Partnership with Copan and New Co-marketing Agreement with Bruker". New Orleans, LA....
-  bioMérieux S.A.. (3/8/11). "Press Release: bioMérieux – 2010 Financial Results". Marcy l’Étoile....
-  Cepheid. (10/13/09). "Press Release: Cepheid Expands Leadership Team with Appointment of Executive Vice President of Worldwide Commercial Operations". Sunnyvale, CA....
-  Ernest C. Manning Awards Foundation. (9/8/09). "Press Release: Canadian Breast Imaging System Ushers in New Era of Breast Cancer Management. Ontario Biomed Engineer Wins Dave Mitchell Award of Distinction". Calgary, AB....
-  Siemens AG. (6/23/09). "Pressemitteilung: Diagnostics. Siemens präsentiert zwei neue Blutgas-Analysesystem der RapidPoint 300-Serie". Erlangen....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »MSC newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]